Pelican Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2009-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)PTX-35 in Patients With Advanced Solid Tumors
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Pelican Therapeutics, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT04430348
- Locations
- 🇺🇸
Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, Oregon, United States
🇺🇸NEXT Oncology Austin, Austin, Texas, United States
🇺🇸Next Oncology, San Antonio, Texas, United States
News
No news found